Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors

NCT00569257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Endometrial Cancer

Interventions

DRUG: AEZS-108

Sponsor

AEterna Zentaris

Collaborators

[object Object]